NASDAQ:WBA
Delisted

Walgreens Boots Alliance Stock News

etoro logo Buy WBA
*Your capital is at risk
$11.98
+0 (+0%)
At Close: Nov 26, 2025
Wolfe Research recommends selling certain stocks based on year-to-date returns and volume-weighted average price, especially before mutual funds' October 31 year-end. Investors should consider tax-los
Can this pharmacy retailer overcome this latest threat?
Dividend stocks should be an investor's priority.
Walgreens (NASDAQ: WBA) is scheduled to report its fiscal Q4 2024 results on Tuesday, October 15 (Walgreens' fiscal ends in August). We expect the company to post mixed results, with revenue of $34.9
Shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) are up 0.8% to trade at $8.99 this afternoon, brushing off this morning's price-target cut to $11 from $13 at Deutsche Bank.
Besides Wall Street's top -and-bottom-line estimates for Walgreens (WBA), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the q
These stocks offer a lot of dividend income, but are they worth the risk?

Buy 4 October Dividend Aristocrats & Watch 10

12:17pm, Wednesday, 09'th Oct 2024
"Dividend Aristocrats... in the S&P500 Index… have raised their annual payouts every year for at least 25 consecutive years." -- Kiplinger.com/Investing. 67 Aristocrats, screened as of October 7, 20
Long-established in the Healthcare Providers & Services industry, Walgreens Boots Alliance Inc (WBA, Financial) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 0.17%, juxta
Walgreens (WBA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With yields of 8% or better at recent prices, these dividend payers are hard to ignore.
In the closing of the recent trading day, Walgreens Boots Alliance (WBA) stood at $8.88, denoting a +1.83% change from the preceding trading day.
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday.

Walgreens: No Catalysts To Drive A Turnaround

09:31am, Thursday, 03'rd Oct 2024
In addition to weak consumer behavior and retail pharmacy industry headwinds, app downloads data suggests Walgreens is lagging vs. competition such as CVS. WBA has missed on margin expectations for mu
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE